Isolyte P in Dextrose is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Dextrose Monohydrate; Sodium Acetate; Potassium Chloride; Magnesium Chloride; Potassium Phosphate, Dibasic.
Product ID | 0264-7730_451ceb0a-c083-4f3d-9c6e-87f10513211c |
NDC | 0264-7730 |
Product Type | Human Prescription Drug |
Proprietary Name | Isolyte P in Dextrose |
Generic Name | Dextrose, Sodium Acetate, Potassium Chloride, Magnesium Chloride, And Potassium Phosphate, Dibasic |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 1993-06-10 |
Marketing Category | NDA / NDA |
Application Number | NDA019873 |
Labeler Name | B. Braun Medical Inc. |
Substance Name | DEXTROSE MONOHYDRATE; SODIUM ACETATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE; POTASSIUM PHOSPHATE, DIBASIC |
Active Ingredient Strength | 5 g/100mL; g/100mL; g/100mL; g/100mL; g/100mL |
Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 1993-06-10 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA019873 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1993-06-10 |
Marketing Category | NDA |
Application Number | NDA019873 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 1993-06-10 |
Marketing End Date | 2011-02-28 |
Ingredient | Strength |
---|---|
DEXTROSE MONOHYDRATE | 5 g/100mL |
SPL SET ID: | 4ea4397c-2fa4-4670-91e6-21ae498c88f7 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |